 

UUID: DASGEAEASI- 66A6- M462F- 948C- 30074FB§561e4d
1A- PR

IIIIIIIIIIIIIIIIIIIIllllll||||||||I||||||||||||||||||||||I||||||
llllllllllllllllllllll lllllllllllllll ||||l| lllllllllllllll
l|||l||||||||||||||||||||||||||||||||||||I |||||||||||| __ _‘

lab _0 ,3 Clinical Case Report
(For Collection of Cancerous Tissue)

QMMW sWWIN (*1
' 8'070/3

5"‘7/ LSWW (W ML

b/DH;

we“; informed Consent!

I personally informed this patient that a specimen(s) would be collected to be used for research

 

 

purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had The patient then signed the

-——_» 431.: _ :«cnmm: nnncanf rinr‘nmpnf will he. retained at
1* Date

 

[Clinical Information!

2:; :‘

Date of Birth (mm/ddlvwv)

E] Single arried

/ Génder D Divorced Cl Widow Blood Pressure Heart Rate

(3 Female

Fit ,. 1 : VJ} .pTOREbETRESENTILLNESS‘»
Chief Complaints: p5 % ouﬂ. ix, bkpcd/J’ow I

Symptoms: Wm w] {,3 Q; :

Clinical Findings:

 

     

 

 

 

 

 

Performance Scale (Karnofsky Score):
60- 70 Symptomatic, in bed less than 50% of day

I: 100 Asymptomatic D 80-90 Symptomatic but Fully Ambulatory
I: 40-50 Symptomatic, in bed more than 50% of day, but 11 bed ridden a 20-30 Bed Ridden

 

 

 

MEDIGATIO ' “
Route

 

w PAST. ICAL’vaTORYQ'Lé“L' V ., _v_ i; ..
Disorder Treatment

e

R ‘ .
Date of First # of
I3 I’m-menopausal
El Peri-Menopausal Date of Last Menses # of Live Births
. El
Birth Control: I: Condom I:I Oral Contraceptive El IUD I:I Hormone Replacement
' D Other:

Environmental Hazards:
! H
5 Current Status Packs ' Duration
3 El YES
1 Alcohol Consum

L TYPE Duration

5 ' Use
é Duration

Relative

Test

HIV U Positive: , Cl C] POSitlve:
B Cl Positive: [3 CI Positive:
C Cl Positive: E] El Positive:

AFP ve 0 Positive: :1 N ve D Positive:

Other:

:1 Negative :1 Positive: l] Negative Ci Positive:

B/T Cell Markers:

 

, DIA OSTIGESTUD
Results

Ultrasound
X-Ra
CT

MRI
Bi

Clinical

Location of Involved L Nodes Location Distant Metastasis

Data of Diagnosis

T Z N M Stage:

 

 

[Treatment Informatioﬂ

“21-3 at Procedure

Tu
Detailed Location

Extension of Tumor

L Nodes
Location of L Nodes Nodes

Palpable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes
Distant Metastasis

Detailed Location

 

Collected by: -

Preserved by:

Frozen
Diseased

Time to LN2

Pathology Form

 

{Specimen Information]

.4 i a-‘i

Parafﬁn Block Slide
Diseased Normal Diseased Normal Diseased Name!

to Formalin Time to LN2
min

‘ «2:31-91?

Prima Tumor
Size Extension of Tumor Distance to NAT

X X

Nodes
# Examined # Metastaslzed

Distant Metastasis

 

 

 

Cell Distribution

Mosaic

Inﬁltration

Vascular Invasion

Alveolar
Indian File

cell
Cell
Secretion

 

Osteoblast

Vacuole

Cellular Differentiation:

Nuclear

Multinucleated Giant Cell

Well 1

Nuclear Grade:

Result

ER
PR
Her-

T Marker

nonunion

Other:

Histological Diagnosis:

I:
a Positive
:I
I:
D Positive
0
D Positive

 

[Final Pathology Reporii

 

Microscopic DescriptitTnl

Moderate

 

L

Small
RS Like
Inflam. Cell
Plasma

Poor

II

 

 

Comments:

 

 

 

Pathologist

uato

 

 
  
  

   
       
    
  
  
 

  

  
  
  

  
     
   

   

 

 

 

 

 

 

 

L.

L!

I L

L’

L A c"I‘iSOI-IDATED DIAGNOSTIC PATHOLOGY roam -
L MieroscopicAppearance:

I.

Q CELL

L Vascular Invasion

L Clusteriaed

2. Cellular

L + -

L Glandularcell

L Cell Cell Stratiﬁcation

L Dmmsome

Poul Gland

Speciﬁed:

D '7 3/2
L 2. Cellular-Di treadmills:

Well Moderately Poor
0K

L

Nuclear

- ~ wag/lame eel/W
Histological Diagnosul. 1 ,
' ~ ( /W &

Commmts: -

 

